Data / Form D filings / Saccharo, Inc.
Saccharo, Inc.: Form D filings
Saccharo, Inc., a biotechnology company in Oakland, CA, filed 2 Form D notices with the SEC between 2022 and 2023. The latest, on September 8, 2023, reports $7.4 million sold of a $10.6 million offering to 45 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6401 CHELTON DRIVE, Oakland, CA, 94611
- Phone
- (510) 219-6741
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1943550
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 8, 2023 | Amendment | $10,629,329 | $7,377,002 | $3,252,327 | 45 | Aug 10, 2022 | sec.gov |
| Aug 22, 2022 | New notice | $10,629,329 | $6,676,993 | $3,952,336 | 40 | Aug 10, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Gregory R. Moe, Ph.D. | Director | |
| Margaret H. Kim | Executive Officer | |
| Sheryl A. Martin-Moe, Ph.D. | Executive Officer, Director | |
| Winnie H. Wan, Ph.D. | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Sep 4, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Saccharo, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.